The United States Food and Drug Administration has chosen Dr Vinay Prasad to lead its Center for Biologics Evaluation and Research.

Nashik: The Archaeological Survey of India (ASI) has sent a letter to Trimbakeshwar police asking them to register an FIR against an individual selling laddus as prasad within the protected temple ...

He added that most people in the role do have such experience — although Marks, the former vaccine chief, was also criticized for having a background in oncology and hematology. Prasad didn’t ...

WASHINGTON (AP) — Dr. Vinay Prasad, a prominent critic of the pharmaceutical industry and the Food and Drug Administration, has been named to oversee the agency’s program for vaccines and biotech ...

The US Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized COVID-19 restrictions, as the director of its Center for Biologics Evaluation and Research ...

WASHINGTON (AP) — Dr. Vinay Prasad, a prominent critic of the pharmaceutical industry and the Food and Drug Administration, has been named to oversee the agency’s program for vaccines and ...

Prasad's new role has traditionally been held by an FDA career scientist, but he will be moving from his position as a hematologist-oncologist and professor at the Department of Epidemiology and ...

(Reuters) - The U.S. Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized the FDA and was a fierce critic of COVID-19 vaccine and mask mandates, as the ...

(Reuters) -The US Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized COVID-19 restrictions, as the director of its Center for Biologics Evaluation and ...

FILE PHOTO: Sign is seen outside of FDA headquarters in White Oak, Maryland 33,714 people played the daily Crossword recently. Can you solve it faster than others?33,714 people played the daily ...

The US Food and Drug Administration has named Dr. Vinay Prasad, a hematologist oncologist, to lead its Center for Biologics ...